Intraventricular conduction delay: a prognostic marker in chronic heart failure

被引:281
作者
Shamim, W
Francis, DP
Yousufuddin, M
Varney, S
Pieopli, MF
Anker, SD
Coats, AJS
机构
[1] Royal Brompton Hosp, London 5W3 6NP, England
[2] Natl Heart & Lung Inst, Dept Cardiac Med, London 5W3 6NP, England
关键词
electrocardiography; prognosis; heart failure; mortality; survival;
D O I
10.1016/S0167-5273(99)00077-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic heart failure (CHF) is associated with high mortality, and there are several established clinical and laboratory parameters that predict mortality in CHF. The purpose of this study was (a) to identify the best ECG parameter that predicts mortality, (b) to evaluate the prognostic marker of ECG against well-established indicators of prognosis. Relevant data from 241 CHF patients were analysed retrospectively. Cardiopulmonary exercise testing and radionuclide ventriculogram were also performed where possible. The mean follow-up period was 31 months. On univariate analysis by the Cox proportional Hazard method, intraventricular conduction delay (IVCD) [P<0.0001, hazard ratio 1.017 (1.011-1.024)] and QTc [P<0.0001, hazard ratio 1.012 (1.006-1.017)] were identified as predictors of mortality. On bivariate analysis, IVCD and MVO2 were better predictors when combined together. A model based on multivariate analysis showed that IVCD, MVO2 and left ventricular ejection fraction (LVEF) were the best predictors of mortality. The addition of plasma sodium, age and NYHA class had no added benefit on the predictive power of the model. Further analysis of IVCD and QTc showed that, for different cut-off values, IVCD is better than QTc, and that there is a graded increase in mortality with increasing value of IVCD. We have found that IVCD is an important ECG predictor of prognosis in patients with CHF. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 36 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[3]  
CLELAND JGF, 1987, BRIT HEART J, V58, P572
[4]   CONTROLLED TRIAL OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE - EXERCISE PERFORMANCE, HEMODYNAMICS, VENTILATION, AND AUTONOMIC FUNCTION [J].
COATS, AJS ;
ADAMOPOULOS, S ;
RADAELLI, A ;
MCCANCE, A ;
MEYER, TE ;
BERNARDI, L ;
SOLDA, PL ;
DAVEY, P ;
ORMEROD, O ;
FORFAR, C ;
CONWAY, J ;
SLEIGHT, P .
CIRCULATION, 1992, 85 (06) :2119-2131
[6]  
COHN JN, 1993, CIRCULATION S, V87, P15
[7]  
CONVERT G, 1980, ARCH MAL COEUR VAISS, V73, P227
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]   CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION IN RELATION TO OCCURRENCE OF CONGESTIVE-HEART-FAILURE [J].
EMANUELSSON, H ;
KARLSON, BW ;
HERLITZ, J .
EUROPEAN HEART JOURNAL, 1994, 15 (06) :761-768
[10]  
GIANFROCCA C, 1992, J ELECTROCARDIOL, V25, P295